Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic.

Noris-García, Elena; Robinson-Agramonte, Maria DE Los Angeles; Gonçalves, Carlos-Alberto

Noris-García, Elena; Robinson-Agramonte, Maria DE Los Angeles; Gonçalves, Carlos-Alberto.

Noris-García E; Instituto de Nefrología, Departamento de Inmunología, Havana, Cuba.
Robinson-Agramonte MLA; Universidad de Ciencias Médicas de La Habana and Centro Internacional de Restauración Neurológica, Departamento de Neuroinmunología, Havana, Cuba.
Gonçalves CA; Universidade Federal do Rio Grande do Sul, Programas de Pós-Graduação em Bioquímica e Neurociências, Porto Alegre, Brazil. Electronic address: casg@ufrgs.br.

Arch Med Res ; 53(5): 543-544, 2022 07.

Article in English | MEDLINE | ID: covidwho-1866881

Subject(s)

COVID-19; Lupus Erythematosus, Systemic; Biomarkers; Humans; Lupus Erythematosus, Systemic/diagnosis; Pandemics; S100 Calcium Binding Protein beta Subunit; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lupus Erythematosus, Systemic Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Arch Med Res Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: J.arcmed.2022.05.004

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google